ASCO: Herceptin Still a Boon for Small Breast Tumors

CHICAGO (MedPage Today) -- The monoclonal antibody trastuzumab (Herceptin) was beneficial for women with small tumors, according to a new meta-analysis of the randomized trials of the drug.
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news